Interrogating androgen receptor function in recurrent prostate cancer

Cancer Research

Volumn 63, Issue 15, 2003, Pages 4552-4560

  Zhang, Liqun ^a   Johnson, Mai ^a   Le, Kim H ^a   Sato, Makoto ^a   Ilagan, Romyla ^a   Iyer, Meera ^a   Gambhir, Sanjiv S ^a   Wu, Lily ^a   Carey, Michael ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANDROGEN RECEPTOR; LUCIFERASE; PROSTATE SPECIFIC ANTIGEN; RNA POLYMERASE II; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR IIB; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CASTRATION; CHROMATIN; CONTROLLED STUDY; ENHANCER REGION; GENE CASSETTE; HUMAN; IMMUNOHISTOCHEMISTRY; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN LOCALIZATION; RECURRENT CANCER; REPORTER GENE; SCID MOUSE; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT;

ADENOVIRIDAE; ANIMALS; CHROMATIN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, SCID; NEOPLASM RECURRENCE, LOCAL; NEOPLASM TRANSPLANTATION; NEOPLASMS, HORMONE-DEPENDENT; PRECIPITIN TESTS; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0041633910     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Gelmann, E. P. Molecular biology of the androgen receptor. J. Clin. Oncol., 20: 3001-3015, 2002.
2. Freedman, L. P. Increasing the complexity of coactivation in nuclear receptor signaling. Cell, 97: 5-8, 1999.
3. Waller, A. S., Sharrard, R. M., Berthon, P., and Maitland, N. J. Androgen receptor localisation and turnover in human prostate epithelium treated with the antiandrogen, casodex. J. Mol. Endocrinol., 24: 339-251, 2000.
4. Tyagi, R. K., Lavrovsky, Y., Ahn, S. C., Song, C. S., Chatterjee, B., and Roy, A. K. Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells. Mol. Endocrinol., 14: 1162-1174, 2000.
5. Bok, R. A., and Small, E. J. Bloodborne biomolecular markers in prostate cancer development and progression. Nat. Rev. Cancer, 2: 918-926, 2002.
6. Pang, S., Taneja, S., Dardashti, K., Cohan, P., Kaboo, R., Sokoloff, M., Tso, C. L., Dekernion, J. B., and Belldegrun, A. S. Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer. Hum. Gene Ther., 6: 1417-1426, 1995.
7. Pang, S., Dannull, J., Kaboo, R., Xie, Y., Tso, C. L., Michel, K., deKernion, J. B., and Belldegrun, A. S. Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen. Cancer Res., 57: 495-499, 1997.
8. Schuur, E. R., Henderson, G. A., Kmetec, L. A., Miller, J. D., Lamparski, H. G., and Henderson, D. R. Prostate-specific antigen expression is regulated by an upstream enhancer. J. Biol. Chem., 271: 7043-7051, 1996.
9. Cleutjens, K. B., van Eekelen, C. C., van der Korput, H. A., Brinkman, A. O., and Trapman, J. Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specfic antigen promoter. J. Biol. Chem., 271: 6379-6388, 1996.
10. Cleutjens, K. B., van der Korput, H. A., van Eekelen, C. C., van Rooij, H. C., Faber, P. W., and Trapman, J. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. Mol. Endocrinol., 11: 148-161, 1997.
11. Cleutjens, K. B., van der Korput, H. A., Ehren-van Eekelen, C. C., Sikes, R. A., Fasciana, C., Chung, L. W., and Trapman, J. A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans. Mol. Endocrinol., 11: 1256-1265, 1997.
12. Zhang, S., Murtha, P. E., and Young, C. Y. Defining a functional androgen responsive element in the 5′ far upstream flanking region of the prostate-specific antigen gene. Biochem. Biophys. Res. Commun., 231: 784-788, 1997.
13. Huang, W., Shostak, Y., Tarr, P., Sawyers, C., and Carey, M. Cooperative assembly of androgen receptor into a nucleoprotein complex that regulates the prostate-specific antigen enhancer. J. Biol. Chem., 274: 25756-25768, 1999.
14. Reid, K. J., Hendy, S. C., Saito, J., Sorensen, P., and Nelson, C. C. Two classes of androgen receptor elements mediate cooperativity through allosteric interactions. J. Biol. Chem., 276: 2943-2952, 2001.
15. Kang, Z., Pirskanen, A., Janne, O. A., and Palvimo, J. J. Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J. Biol. Chem., 277: 48366-48371, 2002.
16. Louie, M. C., Yang, H. Q., Ma, A. H., Xu, W., Zou, J. X., Kung, H. J., and Chen, H. W. Androgen-induced recruitment of RNA polymerase II to a nuclear receptor-p160 coactivator complex. Proc. Natl. Acad. Sci. USA, 100: 2226-2230, 2003.
17. Shang, Y., Myers, M., and Brown, M. Formation of the androgen receptor transcription complex. Mol. Cell, 9: 601-610, 2002.
18. Lee, C. T., and Oesterling, J. E. Diagnostic markers of prostate cancer: utility of prostate-specific antigen in diagnosis and staging. Semin. Surg. Oncol., 11: 23-35, 1995.
19. Abate-Shen, C., and Shen, M. M. Molecular genetics of prostate cancer. Genes Dev., 14: 2410-2434, 2000.
20. Arnold, J. T., and Isaacs, J. T. Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault. Endocr. Relat. Cancer, 9: 61-73, 2002.
21. Feldman, B. J., and Feldman, D. The development of androgen-independent prostate cancer. Nat. Rev. Cancer, 1: 34-45, 2001.
22. Gregory, C. W., Johnson, R. T., Jr., Mohler, J. L., French, F. S., and Wilson, E. M. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Cancer Res., 61: 2892-2898, 2001.
23. Visakorpi, T., Hyytinen, E., Koivisto, P., Tanner, M., Keinanen, R., Palmberg, C., Palotie, A., Tammela, T., Isola, J., and Kallioniemi, O. P. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat. Genet., 9: 401-406, 1995.
24. Stanbrough, M., Leav, I., Kwan, P. W., Bubley, G. J., and Balk, S. P. Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium. Proc. Natl. Acad. Sci. USA, 98: 10823-10828, 2001.
25. Gregory, C. W., He, B., Johnson, R. T., Ford, O. H., Mohler, J. L., French, F. S., and Wilson, E. M. A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res., 61: 4315-4319, 2001.
26. Han, G., Foster, B. A., Mistry, S., Buchanan, G., Harris, J. M., Tilley, W. D., and Greenberg, N. M. Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in autochthonous prostate cancer. J. Biol. Chem., 276: 11204-11213, 2001.
27. Grossmann, M. E., Huang, H., and Tindall, D. J. Androgen receptor signaling in androgen-refractory prostate cancer. J. Natl. Cancer Inst., 93: 1687-1697, 2001.
28. Craft, N., and Sawyers, C. L. Mechanistic concepts in androgen-dependence of prostate cancer. Cancer Metastasis Rev., 17: 421-427, 1998.
29. Elo, J. P., and Visakorpi, T. Molecular genetics of prostate cancer. Ann. Med., 33: 130-141, 2001.
30. Gioeli, D., Mandell, J. W., Petroni, G. R., Frierson, H. F., Jr., and Weber, M. J. Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res., 59: 279-284, 1999.
31. Mellinghoff, I. K., Tran, C., and Sawyers, C. L. Growth inhibitory effects of the dual ErbB1/ErbB2 tyrosine kinase inhibitor PKI-166 on human prostate cancer xenografts. Cancer Res., 62: 5254-5259, 2002.
32. Zegarra-Moro, O. L., Schmidt, L. J., Huang, H., and Tindall, D. J. Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. Cancer Res., 62: 1008-1013, 2002.
33. Kousteni, S., Bellido, T., Plotkin, L. I., O'Brien, C. A., Bodenner, D. L., Han, L., Han, K., DiGregorio, G. B., Katzenellenbogen, J. A., Katzenellenbogen, B. S., Roberson, P. K., Weinstein, R. S., Jilka, R. L., and Manolagas, S. C. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell, 104: 719-730, 2001.
34. Peterziel, H., Mink, S., Schonert, A., Becker, M., Klocker, H., and Cato, A. C. Rapid signalling by androgen receptor in prostate cancer cells. Oncogene, 18: 6322-6329, 1999.
35. Yeung, F., Li, X., Ellett, J., Trapman, J., Kao, C., and Chung, L. W. Regions of prostate-specific antigen (PSA) promoter confer androgen-independent expression of PSA in prostate cancer cells. J. Biol. Chem., 275: 40846-40855, 2000.
36. Klein, K. A., Reiter, R. E., Redula, J., Moradi, H., Zhu, X. L., Brothman, A. R., Lamb, D. J., Marcelli, M., Belldegrun, A., Witte, O. N., and Sawyers, C. L. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nat. Med., 3: 402-408, 1997.
37. Contag, C. H., Jenkins, D., Contag, P. R., and Negrin, R. S. Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia, 2: 41-52, 2000.
38. Contag, P. R. Whole-animal cellular and molecular imaging to accelerate drug development. Drug Disc. Today, 7: 555-562, 2002.
39. Herschman, H. R., MacLaren, D. C., Iyer, M., Namavari, M., Bobinski, K., Green, L. A., Wu, L., Berk, A. J., Toyokuni, T., Barrio, J. R., Cherry, S. R., Phelps, M. E., Sandgren, E. P., and Gambhir, S. S. Seeing is believing: non-invasive, quantitative and repetitive imaging of reporter gene expression in living animals, using positron emission tomography. J. Neurosci. Res., 59: 699-705, 2000.
40. Massoud, T., and Gambhir, S. S. Molecular imaging in living subjects: Seeing fundamental biological processes in a new light. Genes Dev., 17: 545-580, 2003.
41. O'Connell-Rodwell, C. E., Burns, S. M., Bachmann, M. H., and Contag, C. H. Bioluminescent indicators for in vivo measurements of gene expression. Trends Biotechnol., 20: S19-S23, 2002.
42. Wu, J. C., Sundaresan, G., Iyer, M., and Gambhir, S. S. Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. Mol. Ther., 4: 297-306, 2001.
43. Wu, L., Matherly, J., Smallwood, A., Adams, J. Y., Billick, E., Belldegrun, A., and Carey, M. Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors. Gene Ther., 8: 1416-1426, 2001.
44. Adams, J. Y., Johnson, M., Sato, M., Berger, F., Gambhir, S. S., Carey, M., Iruela-Arispe, M. L., and Wu, L. Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging. Nat. Med., 8: 891-897, 2002.
45. Iyer, M., Wu, L., Carey, M., Wang, Y., Smallwood, A., and Gambhir, S. S. Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters. Proc. Natl. Acad. Sci. USA, 98: 14595-14600, 2001.
46. Zhang, L., Adams, J. Y., Billick, E., Ilagan, R., Iyer, M., Le, K., Smallwood, A., Gambhir, S. S., Carey, M., and Wu, L. Molecular engineering of a two-step transcription amplification (TSTA) system for transgene delivery in prostate cancer. Mol. Ther., 5: 223-232, 2002.
47. He, T. C., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., and Vogelstein, B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA, 95: 2509-2514, 1998.
48. Pfeifer, A., and Verma, I. M. Gene therapy: promises and problems. Annu. Rev. Genomics Hum. Genet., 2: 177-211, 2001.
49. Horoszewicz, J. S., Leong, S. S., Kawinski, E., Karr, J. P., Rosenthal, H., Chu, T. M., Mirand, E. A., and Murphy, G. P. LNCaP model of human prostatic carcinoma. Cancer Res., 43: 1809-1818, 1983.
50. Tilley, W. D., Wilson, C. M., Marcelli, M., and McPhaul, M. J. Androgen receptor gene expression in human prostate carcinoma cell lines. Cancer Res., 50: 5382-5386, 1990.
51. Montgomery, B. T., Young, C. Y., Bilhartz, D. L., Andrews, P. E., Prescott, J. L., Thompson, N. F., and Tindall, D. J. Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP. Prostate, 21: 63-73, 1992.
52. Chen, C. D., and Sawyers, C. L. NF-κ B activates prostate-specific antigen expression and is upregulated in androgen-independent prostate cancer. Mol. Cell. Biol., 22: 2862-2870, 2002.
53. Cosma, M. Ordered recruitment: gene-specific mechanism of transcription activation. Mol. Cell, 10: 227-236, 2002.
54. Gilmour, D. S., and Lis, J. T. RNA polymerase II interacts with the promoter region of the noninduced hsp70 gene in Drosophila melanogaster cells. Mol. Cell. Biol., 6: 3984-3989, 1986.
55. Morillon, A., O'Sullivan, J., Azad, A., Proudfoot, N., and Mellor, J. Regulation of elongating RNA polymerase II by forkhead transcription factors in yeast. Science (Wash. DC), 300: 492-495, 2003.